Editorial: Endocrine imbalances of mineral ions and vitamins in chronic disease pathogenesis.
作者信息
Hartman Mor-Li, Abdelhady Hosam G, Razzaque Mohammed S
机构信息
The ADA Forsyth Institute, Cambridge, MA, United States.
College of Osteopathic Medicine, Sam Houston State University, Conroe, TX, United States.
出版信息
Front Endocrinol (Lausanne). 2025 Aug 29;16:1667610. doi: 10.3389/fendo.2025.1667610. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Endocrine imbalances of mineral ions and vitamins in chronic disease pathogenesis.
Front Endocrinol (Lausanne). 2025 Aug 29;16:1667610. doi: 10.3389/fendo.2025.1667610. eCollection 2025.
3
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults With X-Linked Hypophosphatemia.
J Bone Miner Res. 2025 May 2. doi: 10.1093/jbmr/zjaf063.
4
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.
J Bone Miner Res. 2024 Sep 26;39(10):1493-1502. doi: 10.1093/jbmr/zjae127.
5
Vitamin Status in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2024 May 7;25(10):5065. doi: 10.3390/ijms25105065.
6
Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.
Bone. 2024 Apr;181:117044. doi: 10.1016/j.bone.2024.117044. Epub 2024 Feb 6.
7
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin D.
Pediatr Nephrol. 2025 Jun 10. doi: 10.1007/s00467-025-06841-y.
8
X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.
Calcif Tissue Int. 2025 Sep 9;116(1):120. doi: 10.1007/s00223-025-01415-4.
9
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.
J Clin Endocrinol Metab. 2025 Feb 17. doi: 10.1210/clinem/dgaf093.
10
Recombinant growth hormone therapy for X-linked hypophosphatemia in children.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004447. doi: 10.1002/14651858.CD004447.pub2.
本文引用的文献
1
Can targeting the FGF23-αKlotho signaling system delay phosphate-driven organ damage?
Expert Opin Ther Targets. 2025 Mar;29(3):93-100. doi: 10.1080/14728222.2025.2482552. Epub 2025 Mar 28.
2
Minerals and Human Health: From Deficiency to Toxicity.
Nutrients. 2025 Jan 26;17(3):454. doi: 10.3390/nu17030454.
3
Editorial: Endocrine regulation of mineral ions and their relevance to metabolic diseases.
Front Endocrinol (Lausanne). 2024 Apr 3;15:1391096. doi: 10.3389/fendo.2024.1391096. eCollection 2024.
4
The Role of Vitamin D in Health and Disease: A Narrative Review on the Mechanisms Linking Vitamin D with Disease and the Effects of Supplementation.
Drugs. 2023 Jun;83(8):665-685. doi: 10.1007/s40265-023-01875-8. Epub 2023 May 6.
5
Environmental Triggers of Hyperuricemia and Gout.
Rheum Dis Clin North Am. 2022 Nov;48(4):891-906. doi: 10.1016/j.rdc.2022.06.009.
6
Interactions between FGF23 and vitamin D.
Endocr Connect. 2022 Sep 26;11(10). doi: 10.1530/EC-22-0239. Print 2022 Oct 1.
7
Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis.
Front Immunol. 2022 Aug 12;13:930244. doi: 10.3389/fimmu.2022.930244. eCollection 2022.
8
Antioxidant effects of Se-glutathione peroxidase in alcoholic liver disease.
J Trace Elem Med Biol. 2022 Dec;74:127048. doi: 10.1016/j.jtemb.2022.127048. Epub 2022 Jul 29.
9
Dietary patterns and the risks of metabolic syndrome and insulin resistance among young adults: Evidence from a longitudinal study.
Clin Nutr. 2022 Jul;41(7):1523-1531. doi: 10.1016/j.clnu.2022.05.006. Epub 2022 May 18.
10
Phosphate Dysregulation and Neurocognitive Sequelae.
Adv Exp Med Biol. 2022;1362:151-160. doi: 10.1007/978-3-030-91623-7_13.
Zotero 插件